• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Top 5 AJMC® Articles of April 2019

Article

Here are the top 5 articles for the month of April.

Hi, I’m Jaime Rosenberg for The American Journal of Managed Care. Here are the top 5 articles from the month of April.

Number 5: After a year in development, the Community Oncology Alliance is set to file its alternative to CMS’ Oncology Care Model with the Physician-Focused Payment Model Technical Advisory Committee.

Number 4: Results from a recent study indicate that a revolutionary treatment may have the potential to slow, stop, or even reverse the progression of Parkinson disease.

Number 3: Oncologists and hematologists welcomed a clarification from the CDC about the use of opioid pain relief for patients with cancer, past cancer, or sickle cell disease.

Number 2: Based on results of the REDUCE-IT study, Amarin has submitted a supplemental new drug application for an expanded label for its drug Vascepa, which was also included in a mid-year update to the American Diabetes Association’s 2019 Standards of Medical Care in Diabetes.

Number 1: Results from the CREDENCE trial demonstrated that type 2 diabetes drug canagliflozin cut the risk of renal failure or death by 30% in patients with type 2 diabetes and chronic kidney disease.

To read all of these articles and more, visit AJMC.com.

Related Videos
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Stephen Nicholls, MD, Monash University and Victorian Heart Hospital
Amal Agarwal, DO, MBA
Dr Robert Groves
Dr Robert Groves
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.